Early markers (BDNF, pancreatic amyloid, Nrf2, receptor of advanced glycosylation end products—RAGE) should be tested to improve prevention and delete or avoid the negative consequences of dementia in animal models and even in human beings with a special study of the interaction of Aβ with glial cells. The gene discussed is BDNF; the disease is dementia.